Literature DB >> 33300882

Barriers to Creating Scalable Business Models for Digital Health Innovation in Public Systems: Qualitative Case Study.

Leah Taylor Kelley1, Jamie Fujioka1, Kyle Liang1, Madeline Cooper1, Trevor Jamieson2, Laura Desveaux1,3.   

Abstract

BACKGROUND: Health systems are increasingly looking toward the private sector to provide digital solutions to address health care demands. Innovation in digital health is largely driven by small- and medium-sized enterprises (SMEs), yet these companies experience significant barriers to entry, especially in public health systems. Complex and fragmented care models, alongside a myriad of relevant stakeholders (eg, purchasers, providers, and producers of health care products), make developing value propositions for digital solutions highly challenging.
OBJECTIVE: This study aims to identify areas for health system improvement to promote the integration of innovative digital health technologies developed by SMEs.
METHODS: This paper qualitatively analyzes a series of case studies to identify health system barriers faced by SMEs developing digital health technologies in Canada and proposed solutions to encourage a more innovative ecosystem. The Women's College Hospital Institute for Health System Solutions and Virtual Care established a consultation program for SMEs to help them increase their innovation capacity and take their ideas to market. The consultation involved the SME filling out an onboarding form and review of this information by an expert advisory committee using guided considerations, leading to a recommendation report provided to the SME. This paper reports on the characteristics of 25 SMEs who completed the program and qualitatively analyzed their recommendation reports to identify common barriers to digital health innovation.
RESULTS: A total of 2 central themes were identified, each with 3 subthemes. First, a common barrier to system integration was the lack of formal evaluation, with SMEs having limited resources and opportunities to conduct such an evaluation. Second, the health system's current structure does not create incentives for clinicians to use digital technologies, which threatens the sustainability of SMEs' business models. SMEs faced significant challenges in engaging users and payers from the public system due to perverse economic incentives. Physicians are compensated by in-person visits, which actively works against the goals of many digital health solutions of keeping patients out of clinics and hospitals.
CONCLUSIONS: There is a significant disconnect between the economic incentives that drive clinical behaviors and the use of digital technologies that would benefit patients' well-being. To encourage the use of digital health technologies, publicly funded health systems need to dedicate funding for the evaluation of digital solutions and streamlined pathways for clinical integration. ©Leah Taylor Kelley, Jamie Fujioka, Kyle Liang, Madeline Cooper, Trevor Jamieson, Laura Desveaux. Originally published in JMIR Public Health and Surveillance (http://publichealth.jmir.org), 10.12.2020.

Entities:  

Keywords:  digital technologies; evaluation study; health policy; incentive; innovation diffusion; mobile phone; reimbursement; telemedicine

Mesh:

Year:  2020        PMID: 33300882      PMCID: PMC7759439          DOI: 10.2196/20579

Source DB:  PubMed          Journal:  JMIR Public Health Surveill        ISSN: 2369-2960


  19 in total

1.  Academic Medical Centers as digital health catalysts.

Authors:  Jacqueline W DePasse; Connie E Chen; Aenor Sawyer; Kamal Jethwani; Ida Sim
Journal:  Healthc (Amst)       Date:  2014-07-11

Review 2.  Telemedicine, telehealth, and mobile health applications that work: opportunities and barriers.

Authors:  Ronald S Weinstein; Ana Maria Lopez; Bellal A Joseph; Kristine A Erps; Michael Holcomb; Gail P Barker; Elizabeth A Krupinski
Journal:  Am J Med       Date:  2013-10-29       Impact factor: 4.965

3.  Clinical considerations when applying machine learning to decision-support tasks versus automation.

Authors:  Trevor Jamieson; Avi Goldfarb
Journal:  BMJ Qual Saf       Date:  2019-05-30       Impact factor: 7.035

4.  Catalyzing Digital Health Innovation in Ontario: The Role of an Academic Medical Centre.

Authors:  Laura Desveaux; Leah T Kelley; R Sacha Bhatia; Trevor Jamieson
Journal:  Healthc Policy       Date:  2020-11

5.  Evaluating Digital Health Interventions: Key Questions and Approaches.

Authors:  Elizabeth Murray; Eric B Hekler; Gerhard Andersson; Linda M Collins; Aiden Doherty; Chris Hollis; Daniel E Rivera; Robert West; Jeremy C Wyatt
Journal:  Am J Prev Med       Date:  2016-11       Impact factor: 5.043

Review 6.  Legal and organizational aspects of remote cardiac monitoring: the example of implantable cardioverter defibrillators.

Authors:  Imgard Vinck; Chris De Laet; Serge Stroobandt; Hans Van Brabandt
Journal:  Europace       Date:  2012-02-15       Impact factor: 5.214

7.  Grand challenges in digital health.

Authors:  Patty Kostkova
Journal:  Front Public Health       Date:  2015-05-05

8.  Examining Tensions That Affect the Evaluation of Technology in Health Care: Considerations for System Decision Makers From the Perspective of Industry and Evaluators.

Authors:  Laura Desveaux; James Shaw; Ross Wallace; Onil Bhattacharyya; R Sacha Bhatia; Trevor Jamieson
Journal:  JMIR Med Inform       Date:  2017-12-08

9.  Establishing Standards to Evaluate the Impact of Integrating Digital Health into Health Systems.

Authors:  Alain Labrique; Lavanya Vasudevan; William Weiss; Kate Wilson
Journal:  Glob Health Sci Pract       Date:  2018-10-10

10.  Digital Health Innovation: A Toolkit to Navigate From Concept to Clinical Testing.

Authors:  Francoise Adeline Marvel; Jane Wang; Seth Shay Martin
Journal:  JMIR Cardio       Date:  2018-01-18
View more
  1 in total

Review 1.  Applications of Digital Health Technologies in Knee Osteoarthritis: Narrative Review.

Authors:  Nirali Shah; Kerry Costello; Akshat Mehta; Deepak Kumar
Journal:  JMIR Rehabil Assist Technol       Date:  2022-06-08
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.